EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

Beyond Nature's Blueprint: Macrocyclic Peptides Containing Unnatural Amino Acids in Therapeutic Development

Krishna K Sharma iD, Komal Sharma iD, Anku Sharma iD, Kamya Rao iD, Rahul Jain iD, Brett VanVeller iD

Angewandte Chemie International Edition · 02.11.2026 · 65 (45)

DOI: 10.1002/anie.202523959 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Angewandte Chemie International Edition, online erschienen am 16.09.2026. Verfasst von Krishna K Sharma und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, East Tennessee State University, Johnson City, Tennessee, USA. Hauptthemen laut MEDLINE: Amino Acids, Peptides, Cyclic, Macrocyclic Compounds, Peptides. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 130 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIGMS NIH HHS, Foundation for the National Institutes of Health, Iowa State University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Macrocyclic peptides have emerged as a compelling class of therapeutics, combining the modularity and synthetic accessibility of small molecules with the high affinity and target selectivity of biologics. Their ability to engage challenging and traditionally “undruggable” protein targets—including protein–protein interactions and allosteric sites—has generated widespread interest. However, pharmacokinetic limitations such as poor oral bioavailability, metabolic instability, and low membrane permeability continue to hinder clinical translation. The strategic incorporation of unnatural amino acids (UAAs) has proven critical for overcoming these challenges, enabling fine‐tuning of key physicochemical and pharmacological properties. In this review, we highlight recent clinical advances—including motixafortide and zilucoplan—and examine how UAAs are deployed to optimize drug‐like characteristics across diverse therapeutic areas. We discuss emerging strategies, illustrative case studies, and design principles that collectively support the development of next‐generation macrocyclic peptide drugs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Amino AcidsPeptides, CyclicMacrocyclic CompoundsPeptidesHumans

Stichwörter der Autor:innen

drug discoverymacrocyclic peptidesmedicinal agentsunnatural amino acids

Substanzen

Amino AcidsPeptides, CyclicMacrocyclic CompoundsPeptides

Autor:innen und Institutionen

  • Department of Chemistry, East Tennessee State University, Johnson City, Tennessee, USA.
  • Department of Medicinal Chemistry, National Institute of Pharmaceutical Education and Research, Punjab, India.
  • Department of Chemistry, Iowa State University, Ames, Iowa, USA.

ORCID-Profile: Krishna K Sharma, Komal Sharma, Anku Sharma, Kamya Rao, Rahul Jain, Brett VanVeller

Förderung

  • NIGMS NIH HHS
  • Foundation for the National Institutes of Health
  • Iowa State University
  • NIH HHS
  • National Institutes of Health

Zitieren

APA

Sharma, K. K., Sharma, K., Sharma, A., Rao, K., Jain, R., & VanVeller, B. (2026). Beyond Nature's Blueprint: Macrocyclic Peptides Containing Unnatural Amino Acids in Therapeutic Development. Angewandte Chemie International Edition, 65(45). https://doi.org/10.1002/anie.202523959

Vancouver

Sharma KK, Sharma K, Sharma A, Rao K, Jain R, VanVeller B. Beyond Nature's Blueprint: Macrocyclic Peptides Containing Unnatural Amino Acids in Therapeutic Development. Angewandte Chemie International Edition. 2026;65(45). doi:10.1002/anie.202523959

BibTeX
@article{Sharma2026,
  author = {Sharma, Krishna K and Sharma, Komal and Sharma, Anku and Rao, Kamya and Jain, Rahul and VanVeller, Brett},
  title = {Beyond Nature's Blueprint: Macrocyclic Peptides Containing Unnatural Amino Acids in Therapeutic Development},
  journal = {Angewandte Chemie International Edition},
  year = {2026},
  volume = {65},
  number = {45},
  doi = {10.1002/anie.202523959}
}
Kostenlos starten →